The DOI matches its Crossref record.
Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
Abstract
Human peripheral blood mononuclear cells (PBMC) were induced by recombinant interleukin 2 and mitogens to secrete two distinct cytotoxic polypeptides, tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor-beta (TNF-beta), previously called lymphotoxin. Treatment of PBMC with recombinant human interleukin 2 (rIL 2) or mitogens in combination with recombinant human interferon-gamma (rIFN-gamma) resulted in augmented production of both TNF-alpha and TNF-beta. rIFN-gamma alone had no effect on production of either cytotoxic polypeptide. TNF-alpha was produced within 2 to 3 hr after induction and was the major cytotoxin produced by PBMC during the first 48 hr of culture, after which time TNF-beta became the predominant species. TNF-beta was first secreted into the media after 8 hr of induction. Enhanced levels of both TNF-alpha and TNF-beta were seen when the PBMC were separated into adherent and nonadherent cells. Both TNF-alpha and TNF-beta were induced in different tumor cell lines of hematopoietic origin. The results demonstrate that the production of TNF-alpha and TNF-beta can be enhanced by two lymphokines, IL 2 and IFN-gamma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationBertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Self-citationCachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,432
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,179
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994) · Science · doi:10.1126/science.8171322 · Cited by 986
The role of inflammatory mediators in the pathogenesis of periodontal disease
Page, R. C. (1991) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1991.tb01649.x · Cited by 902
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
Girardin, E., Grau, G. E., Dayer, J.-M., Roux-Lombard, P., the J5 Study Group*, & Lambert, P.-H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190703 · Cited by 737
Piguet, P. F., Grau, G. E., Allet, B., & Vassalli, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1280 · Cited by 584
Ranges, G. E., Figari, I. S., Espevik, T., & Palladino, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.991 · Cited by 494
Self-citationte Velde, A., Huijbens, R., Heije, K., de Vries, J., & Figdor, C. (1990) · Blood · doi:10.1182/blood.v76.7.1392.1392 · Cited by 449
Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., & Palladino, M. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.2.571 · Cited by 447
Self-citationIn vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L., & Zern, M. A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2477 · Cited by 415
Cytokines as Endogenous Pyrogens
Dinarello, C. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/513856 · Cited by 387
Immunopathogenesis of Dengue Hemorrhagic Fever
Rothman, A. L., & Ennis, F. A. (1999) · Virology · doi:10.1006/viro.1999.9656 · Cited by 369
New Concepts on the Pathogenesis of Fever
Dinarello, C. A., Cannon, J. G., & Wolff, S. M. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.1.168 · Cited by 367
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.
Choi, Y., Lafferty, J. A., Clements, J. R., Todd, J. K., Gelfand, E. W., Kappler, J., Marrack, P., & Kotzin, B. L. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.981 · Cited by 357
Circulating Cytokines as Mediators of Fever
Netea, M. G., Kullberg, B. J., & Van der Meer, J. W. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317513 · Cited by 357
TALL-1 is a novel member of the TNF family that is down-regulated by mitogens
Shu, H.-B., Hu, W.-H., & Johnson, H. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.5.680 · Cited by 355
Stephens, K. E., Ishizaka, A., Larrick, J. W., & Raffin, T. A. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.6.1364 · Cited by 341
Regulation of macrophage tumor necrosis factor production by prostaglandin E2
Kunkel, S. L., Wiggins, R. C., Chensue, S. W., & Larrick, J. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91224-6 · Cited by 333
Nathan, C. F., Kaplan, G., Levis, W. R., Nusrat, A., Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R., Steinman, R. M., & Cohn, Z. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607033150102 · Cited by 323
Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Atkins, M. B., Mier, J. W., Parkinson, D. R., Gould, J. A., Berkman, E. M., & Kaplan, M. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806163182401 · Cited by 318
Wong, H. L., & Wahl, S. M. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-74781-6_18 · Cited by 295
Widner, H., & Brundin, P. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90010-0 · Cited by 287
A Central Role of Perforin in Cytolysis?
Podack, E. R., Hengartner, H., & Lichtenheld, M. G. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001021 · Cited by 280
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., & Grunfeld, C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8313 · Cited by 277
A human inhibitor of tumor necrosis factor alpha.
Seckinger, P., Isaaz, S., & Dayer, J. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1511 · Cited by 255
Trinchieri, G., Kobayashi, M., Rosen, M., Loudon, R., Murphy, M., & Perussia, B. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.4.1206 · Cited by 253
Effects of Sleep on the Production of Cytokines in Humans
Uthgenannt, D., Schoolmann, D., Pietrowsky, R., Fehm, H.-L., & Born, J. (1995) · Psychosomatic Medicine · doi:10.1097/00006842-199503000-00001 · Cited by 112
Vecchiarelli, A., Puliti, M., Torosantucci, A., Cassone, A., & Bistoni, F. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90331-5 · Cited by 74
Metadata
- Authors
- Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A., & Goeddel, D. V.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1985-10-01
- Volume
- 135
- Issue
- 4
- Pages
- 2492-2497
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2131632510
- Cited by
- 485
- References
- 0
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.